AIDS Treatment News
Table of Contents, November 22, 2002

• New Guidelines on Metabolic Complications of HIV and Antiretroviral Treatment
  Experts have published consensus recommendations on lipid abnormalities, fat redistribution, glucose intolerance and diabetes, lactic acidemia, and bone disease.

• Nevirapine Patient Assistance Program: Model for Better Administration?
  Unlike the many notoriously burdensome patient-assistance programs, this one requires a one-page application and proof of income once a year, and sends medicines to the doctor's office.

• Heart-Disease Risk and C-Reactive Protein
  A study of almost 28,000 healthy women has found that this marker of inflammation is a better predictor of heart disease than cholesterol level.

• Vaccine Against Three Kinds of HIV Begins Human Tests
  A vaccine from the new Vaccine Research Center of the U.S. National Institutes of Health is ready to begin human testing.
  Advertisement

• Prevention: New Approach Will Test Tenofovir for Persons at High Risk
  An antiretroviral already in use in HIV treatment will be tested for prevention.

• U.S. AIDS Research Needs Tissue Donations
  National Institutes of Health research projects need donation of tissues, either removed as a byproduct of surgery or collected after death.

• Call for U.S. Action on AIDS, Washington, D.C., November 26
  ACT UP and others want the White House to pay attention to the global AIDS epidemic and to problems in the U.S.

• Drug Patents and Developing Countries: Problems Remain
  Reports from Australia and Nigeria show that this issue has not gone away.

• Marijuana Lung Health Report: Less Than Meets the Eye?
  An international news story on the dangers of marijuana had no new information -- only an unsigned nine-page paper and a press release.

ISSN # 1052-4207

Copyright 2002 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.